🇺🇸 HCV 796 in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 23

Most-reported reactions

1. Alanine Aminotransferase Increased — 6 reports (26.09%)
2. Aspartate Aminotransferase Increased — 6 reports (26.09%)
3. Fatigue — 2 reports (8.7%)
4. Nausea — 2 reports (8.7%)
5. Vomiting — 2 reports (8.7%)
6. Acute Psychosis — 1 report (4.35%)
7. Affect Lability — 1 report (4.35%)
8. Anxiety — 1 report (4.35%)
9. Bilirubin Conjugated Increased — 1 report (4.35%)
10. Blood Albumin Increased — 1 report (4.35%)

Source database →

Frequently asked questions

Is HCV 796 approved in United States?

HCV 796 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for HCV 796 in United States?

Wyeth is now a wholly owned subsidiary of Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.